{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_secukinumab",
          "name": "Secukinumab"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_ixekizumab",
          "name": "Ixekizumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_brodalumab",
          "name": "Brodalumab"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_neratinib",
          "name": "Neratinib"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_tazarotene",
          "name": "Tazarotene"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [
      {
        "hypothesis_id": "H1",
        "score": 0.76,
        "components": {
          "mechanism_fit": 0.9,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.8,
          "indication_plausibility": 0.8,
          "safety_risk": 0.25,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.9,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Acitretin adverse effects",
              "pro": [
                "drug_acitretin"
              ],
              "con": [
                "n_adv_acitretin"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "映射至Th17细胞的已知作用机制"
          ],
          "safety_risk": [
            "存在潜在的不良表型声明"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "需进一步分析Acitretin的安全性与长期效果"
        ]
      },
      {
        "hypothesis_id": "H2",
        "score": 0.72,
        "components": {
          "mechanism_fit": 0.85,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.75,
          "indication_plausibility": 0.75,
          "safety_risk": 0.25,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.9,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Corticosteroids adverse effects",
              "pro": [
                "drug_corticosteroids"
              ],
              "con": [
                "n_adv_corticosteroids"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "抑制TNF机制在治疗炎症方面的有效性"
          ],
          "safety_risk": [
            "存在潜在的不良表型声明"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "需进一步分析Corticosteroids的安全性与长期效果"
        ]
      },
      {
        "hypothesis_id": "H3",
        "score": 0.71,
        "components": {
          "mechanism_fit": 0.8,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.75,
          "safety_risk": 0.3,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.85,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Methotrexate adverse effects",
              "pro": [
                "drug_methotrexate"
              ],
              "con": [
                "n_adv_methotrexate"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "调节免疫通路以治疗炎症"
          ],
          "safety_risk": [
            "存在潜在的不良表型声明"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "需进一步分析Methotrexate的安全性与长期效果"
        ]
      },
      {
        "hypothesis_id": "H4",
        "score": 0.68,
        "components": {
          "mechanism_fit": 0.8,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.75,
          "indication_plausibility": 0.7,
          "safety_risk": 0.35,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.85,
          "contradiction_weight": 0.78,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Infliximab adverse effects",
              "pro": [
                "drug_infliximab"
              ],
              "con": []
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "直接作用于TNF以减少炎症反应"
          ],
          "safety_risk": [
            "少量不良表型声明"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "需进一步分析Infliximab的安全性与长期效果"
        ]
      },
      {
        "hypothesis_id": "H5",
        "score": 0.65,
        "components": {
          "mechanism_fit": 0.8,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.65,
          "safety_risk": 0.35,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 0.7,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "作为TNF抑制剂发挥作用"
          ],
          "safety_risk": [
            "需确认对患者的长期影响"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "需进一步分析Adalimumab的安全性与长期效果"
        ]
      },
      {
        "hypothesis_id": "H6",
        "score": 0.64,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.65,
          "indication_plausibility": 0.6,
          "safety_risk": 0.35,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.75,
          "contradiction_weight": 0.65,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "抑制IL-17以治疗皮肤炎症"
          ],
          "safety_risk": [
            "缺乏足够的长期安全性数据"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "需进一步分析Secukinumab的安全性与长期效果"
        ]
      },
      {
        "hypothesis_id": "H7",
        "score": 0.63,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.5,
          "safety_risk": 0.35,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.7,
          "contradiction_weight": 0.65,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "作用于TNF抑制，减轻炎症"
          ],
          "safety_risk": [
            "需确认可能的副作用"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "需进一步分析Etanercept的安全性与长期效果"
        ]
      },
      {
        "hypothesis_id": "H8",
        "score": 0.62,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.5,
          "safety_risk": 0.35,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.65,
          "contradiction_weight": 0.55,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "抑制IL-17以减轻皮肤炎症"
          ],
          "safety_risk": [
            "缺乏充分的安全性验证"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "需进一步分析Ixekizumab的安全性与长期效果"
        ]
      },
      {
        "hypothesis_id": "H9",
        "score": 0.6,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.55,
          "safety_risk": 0.35,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.6,
          "contradiction_weight": 0.5,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "抑制IL-17的潜在有效性"
          ],
          "safety_risk": [
            "缺乏充分的安全性验证"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "需进一步分析Brodalumab的安全性与长期效果"
        ]
      },
      {
        "hypothesis_id": "H10",
        "score": 0.55,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.4,
          "pk_pd_feasibility": 0.55,
          "indication_plausibility": 0.45,
          "safety_risk": 0.35,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.55,
          "contradiction_weight": 0.5,
          "mechanistic_connectivity": false,
          "path_disjointness": 0,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "对炎症的影响尚不明确"
          ],
          "safety_risk": [
            "缺乏安全性和疗效的强有力数据"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "需进一步分析Neratinib的适用性"
        ]
      },
      {
        "hypothesis_id": "H11",
        "score": 0.5,
        "components": {
          "mechanism_fit": 0.55,
          "class_prior": 0.4,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.45,
          "safety_risk": 0.35,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.5,
          "contradiction_weight": 0.45,
          "mechanistic_connectivity": false,
          "path_disjointness": 0,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "作用机制尚不明确"
          ],
          "safety_risk": [
            "缺乏强有力的支持证据"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "需进一步分析Apremilast的适用性"
        ]
      },
      {
        "hypothesis_id": "H12",
        "score": 0.45,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.4,
          "pk_pd_feasibility": 0.45,
          "indication_plausibility": 0.4,
          "safety_risk": 0.35,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.45,
          "contradiction_weight": 0.4,
          "mechanistic_connectivity": false,
          "path_disjointness": 0,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "作用机制尚不明确"
          ],
          "safety_risk": [
            "缺乏足够证据支持其安全性"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "需进一步分析Tazarotene的适用性"
        ]
      }
    ],
    "ranking": [
      "H1",
      "H2",
      "H3",
      "H4",
      "H5",
      "H6",
      "H7",
      "H8",
      "H9",
      "H10",
      "H11",
      "H12"
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ixekizumab",
          "type": "Drug",
          "label": "Ixekizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_brodalumab",
          "type": "Drug",
          "label": "Brodalumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_neratinib",
          "type": "Drug",
          "label": "Neratinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tazarotene",
          "type": "Drug",
          "label": "Tazarotene",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_gp_psoriasis",
          "type": "Disease",
          "label": "Generalised Pustular Psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_th17",
          "type": "Target",
          "label": "Th17 cells",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_il17",
          "type": "Target",
          "label": "IL-17",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_tnf",
          "type": "Target",
          "label": "TNF",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway_inflammation",
          "type": "Pathway",
          "label": "Inflammatory Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway_immune_response",
          "type": "Pathway",
          "label": "Immune Response Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph1",
          "type": "Phenotype",
          "label": "Skin Inflammation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph2",
          "type": "Phenotype",
          "label": "Pustular Lesions",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_acitretin",
          "type": "Target",
          "label": "OffTarget_Acitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_acitretin",
          "type": "Pathway",
          "label": "RiskPathway_Acitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_acitretin",
          "type": "Phenotype",
          "label": "AdversePhenotype_Acitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_corticosteroids",
          "type": "Target",
          "label": "OffTarget_Corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_corticosteroids",
          "type": "Pathway",
          "label": "RiskPathway_Corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_corticosteroids",
          "type": "Phenotype",
          "label": "AdversePhenotype_Corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_methotrexate",
          "type": "Target",
          "label": "OffTarget_Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_methotrexate",
          "type": "Pathway",
          "label": "RiskPathway_Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_methotrexate",
          "type": "Phenotype",
          "label": "AdversePhenotype_Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Acitretin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Secukinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Etanercept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Ixekizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Brodalumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Neratinib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Apremilast",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Tazarotene",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_acitretin",
          "target": "n_target_th17",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知作用机制"
        },
        {
          "source": "drug_corticosteroids",
          "target": "n_target_tnf",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "常用于抑制炎症"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_pathway_inflammation",
          "relation": "modulates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "影响免疫通路"
        },
        {
          "source": "drug_infliximab",
          "target": "n_target_tnf",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "抗TNF机制"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_target_tnf",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "抗TNF机制"
        },
        {
          "source": "drug_secukinumab",
          "target": "n_target_il17",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "抑制IL-17"
        },
        {
          "source": "drug_etanercept",
          "target": "n_target_tnf",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "抗TNF机制"
        },
        {
          "source": "drug_ixekizumab",
          "target": "n_target_il17",
          "relation": "inhibits",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "抑制IL-17"
        },
        {
          "source": "drug_brodalumab",
          "target": "n_target_il17",
          "relation": "inhibits",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "抑制IL-17"
        },
        {
          "source": "drug_neratinib",
          "target": "n_pathway_inflammation",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "假设影响炎症"
        },
        {
          "source": "drug_apremilast",
          "target": "n_pathway_immune_response",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "影响免疫通路"
        },
        {
          "source": "drug_tazarotene",
          "target": "n_ph1",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "已知治疗效果"
        },
        {
          "source": "n_target_th17",
          "target": "n_pathway_inflammation",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通路联系"
        },
        {
          "source": "n_target_il17",
          "target": "n_pathway_immune_response",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "通路联系"
        },
        {
          "source": "n_target_tnf",
          "target": "n_pathway_inflammation",
          "relation": "involved_in",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "通路联系"
        },
        {
          "source": "n_pathway_inflammation",
          "target": "n_ph1",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与皮肤炎症相关"
        },
        {
          "source": "n_pathway_inflammation",
          "target": "n_ph2",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "与脓疱损伤相关"
        },
        {
          "source": "n_pathway_immune_response",
          "target": "n_ph1",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "免疫通路相关结局"
        },
        {
          "source": "n_pathway_immune_response",
          "target": "n_ph2",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "免疫通路相关结局"
        },
        {
          "source": "drug_acitretin",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_corticosteroids",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_infliximab",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_secukinumab",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_etanercept",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_ixekizumab",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_brodalumab",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_neratinib",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_apremilast",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_tazarotene",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_acitretin",
          "target": "n_ot_acitretin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在旁路作用可能影响其他靶点"
        },
        {
          "source": "n_ot_acitretin",
          "target": "n_rp_acitretin",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响风险通路"
        },
        {
          "source": "n_rp_acitretin",
          "target": "n_adv_acitretin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良表型"
        },
        {
          "source": "n_adv_acitretin",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，可能抵消净获益"
        },
        {
          "source": "drug_corticosteroids",
          "target": "n_ot_corticosteroids",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在旁路作用可能影响其他靶点"
        },
        {
          "source": "n_ot_corticosteroids",
          "target": "n_rp_corticosteroids",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响风险通路"
        },
        {
          "source": "n_rp_corticosteroids",
          "target": "n_adv_corticosteroids",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良表型"
        },
        {
          "source": "n_adv_corticosteroids",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，可能抵消净获益"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_ot_methotrexate",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在旁路作用可能影响其他靶点"
        },
        {
          "source": "n_ot_methotrexate",
          "target": "n_rp_methotrexate",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响风险通路"
        },
        {
          "source": "n_rp_methotrexate",
          "target": "n_adv_methotrexate",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良表型"
        },
        {
          "source": "n_adv_methotrexate",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，可能抵消净获益"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "score": 0.76,
        "graph_snapshot_ref": "GE_H1_round4",
        "key_assumptions": [
          "MOA→ Th17 细胞通路影响皮肤炎症",
          "安全性需要更深入的分析和验证"
        ],
        "caveats": [
          "潜在的不良反应尚需更多证据支持"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "score": 0.72,
        "graph_snapshot_ref": "GE_H2_round4",
        "key_assumptions": [
          "具有抑制 TNF 和抗炎作用的机制",
          "安全性需要进一步的探索和验证"
        ],
        "caveats": [
          "潜在的不良反应需考量"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "score": 0.71,
        "graph_snapshot_ref": "GE_H3_round4",
        "key_assumptions": [
          "调节免疫通路以治疗皮肤炎症",
          "安全性与有效性索要进一步的研究支撑"
        ],
        "caveats": [
          "潜在的不良反应需识别"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Target (Th17/TNF)→Inhibition→Generalised Pustular Psoriasis",
          "reason": "大多数假设能够通过已知的抗炎机制直接支持该疾病"
        }
      ],
      "remaining_gaps": [
        "安全性与长期效果的数据缺口依然存在"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [],
          "impact_summary": "初步探索已知药物的有效性"
        },
        {
          "round": 2,
          "seeds": [],
          "impact_summary": "现存假设已基本覆盖主要适应症"
        },
        {
          "round": 3,
          "seeds": [],
          "impact_summary": "对各种可能的不良反应进行了议题讨论"
        },
        {
          "round": 4,
          "seeds": [],
          "impact_summary": "需针对特定药物的安全性进一步生成研究目标"
        }
      ],
      "lessons": [
        "需结合实际临床安全性证据支持潜在治疗",
        "针对不良反应进行持续的监测与研究"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "针对不同药物的安全性与长期效果进行较深入的分析。"
      },
      {
        "role": "Skeptic",
        "patch": "明确标注潜在不良反应，描述其可能影响的临床结果。"
      },
      {
        "role": "Explorer",
        "patch": "关注更新药物的非临床疗效支撑，确保所有药物为新适应症带来科学有效的证据。"
      }
    ],
    "heuristics": [
      {
        "when": "针对特定皮肤病",
        "then": "重视疗效与可能的不良反应监测的平衡"
      },
      {
        "when": "中枢免疫相关疾病",
        "then": "建议综合评估疗效和安全特征，确保患者受益最大化"
      }
    ]
  }
}